World Health Organization site
Skip Navigation Links

Main
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register.
Register: ClinicalTrials.gov
Last refreshed on: 16 December 2017
Main ID:  NCT02025452
Date of registration: 28/12/2013
Prospective Registration: Yes
Primary sponsor: Jeffrey Pernica
Public title: Novel Diagnostics and Probiotics to Improve Management of Paediatric Acute Gastroenteritis
Scientific title: Rapid Diagnostics and Probiotic Therapy for Paediatric Acute Gastroenteritis - a Randomized, Factorial, Controlled, Placebo-controlled, Pilot Trial
Date of first enrolment: March 2014
Target sample size: 76
Recruitment status: Completed
URL:  https://clinicaltrials.gov/show/NCT02025452
Study type:  Interventional
Study design:  Allocation: Randomized. Intervention model: Factorial Assignment. Primary purpose: Treatment. Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor).  
Phase:  Phase 4
Countries of recruitment
Botswana
Contacts
Name:     Jeffrey Pernica, MD
Address: 
Telephone:
Email:
Affiliation:  McMaster University
Key inclusion & exclusion criteria

Inclusion Criteria:

- acute non-bloody gastroenteritis

Exclusion Criteria:

- diarrhoea > 14 days

- sepsis, pneumonia, UTI, meningitis requiring empiric antibiotic therapy

- malignancy, IBD

- known link to another patient with diarrhoea of defined aetiology

- transferred in already on antimicrobials

- live outside study area

- children with severe acute malnutrition will be eligible for diagnostic arm but not
probiotic arm



Age minimum: 2 Months
Age maximum: 60 Months
Gender: All
Health Condition(s) or Problem(s) studied
Acute Gastroenteritis
Intervention(s)
Other: Placebo
Dietary Supplement: Probiotic
Other: Rapid diagnostic
Primary Outcome(s)
Height z-score (HAZ) adjusted for initial HAZ [Time Frame: 60 days post-enrollment]
Secondary Outcome(s)
duration of diarrhoea [Time Frame: estimated average duration ~ 4 days.]
environmental enteropathy score [Time Frame: 60 days post-enrollment]
mortality [Time Frame: 60 days post-enrollment]
Weight z-score (WAZ) adjusted for initial WAZ [Time Frame: 60 days after enrolment]
Secondary ID(s)
HHS 13-749
Source(s) of Monetary Support
Please refer to primary and secondary sponsors
Secondary Sponsor(s)
Grand Challenges Canada
BioGaia AB
Ethics review
Results
Results available:
Date Posted:
Date Completed:
URL:
Disclaimer: Trials posted on this search portal are not endorsed by WHO, but are provided as a service to our users. In no event shall the World Health Organization be liable for any damages arising from the use of the information linked to in this section. None of the information obtained through use of the search portal should in any way be used in clinical care without consulting a physician or licensed health professional. WHO is not responsible for the accuracy, completeness and/or use made of the content displayed for any trial record.
Copyright - World Health Organization - Version 3.6 - Version history